Does EU legislation allow the use of the Benchmark dose (BMD) approach for risk assessment?

Title
Does EU legislation allow the use of the Benchmark dose (BMD) approach for risk assessment?
Authors
Keywords
-
Journal
REGULATORY TOXICOLOGY AND PHARMACOLOGY
Volume 67, Issue 2, Pages 182-188
Publisher
Elsevier BV
Online
2013-07-17
DOI
10.1016/j.yrtph.2013.07.005

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now